← Overview

Strategic Lens

Pharma and health: Taiwan and United States

First country

Second country

In 2025, Taiwan sold USD 562 million of pharmaceutical products to United States and bought USD 507 million from it.

Benefits

  • BothTrade in pharmaceutical products runs both ways in similar amounts: Taiwan sold USD 562 million and United States sold USD 507 million in 2025.
  • BothTwo-way trade in pharmaceutical products grew 72 percent, from USD 621 million in 2019 to USD 1.07 billion in 2025.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

United States's imports from Taiwan: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by United States

2019: 206.3Low 206.3 / High 646.62025: 561.9

2019206.3
2020210.1
2021391.8
2022379.4
2023646.6
2024361
2025561.9

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

United States's exports to Taiwan: pharmaceutical products

USD billion · 2019 to 2025, calendar years, as reported by United States

2019: 0.42Low 0.42 / High 1.012025: 0.51

20190.42
20200.48
20210.61
20221.01
20230.83
20240.6
20250.51

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

← Taiwan and United States